(Q37128257)

18 August 2017

1 reference

title

Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination (English)

1 reference

18 August 2017

0 references

1 reference

Alexandre Iannello

1

1 reference

18 August 2017

Olfa Debbeche

series ordinal

2

1 reference

18 August 2017

Suzanne Samarani

series ordinal

3

1 reference

18 August 2017

Ali Ahmad

series ordinal

4

1 reference

18 August 2017

language of work or name

1 reference

3 April 2008

1 reference

Journal of Leukocyte Biology

18 August 2017

published in

1 reference

18 August 2017

volume

84

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

27-49

1 reference

Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Relative preservation of natural killer cell cytotoxicity and number in healthy AIDS patients with low CD4 cell counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Differential NKp30 inducibility in chimpanzee NK cells and conserved NK cell phenotype and function in long-term HIV-1-infected animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Natural killer (NK) cell activity during HIV infection: a decrease in NK activity is observed at the clonal level and is not restored after in vitro long-term culture of NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Analysis of the cytolytic activity mediated by natural killer cells from acquired immunodeficiency syndrome patients in response to phytohemagglutinin or anti-CD16 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Defective natural immunity: an early manifestation of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Clinical progression of HIV infection: role of NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Expression of killer inhibitory receptors on cytotoxic cells from HIV-1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Natural immunity and HIV disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Uncoupling activation-induced modulation of CD16 and CD69 in CD56+ cells during AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

HLA-E Up-Regulation Induced by HIV Infection May Directly Contribute to CD94-Mediated Impairment of NK Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Low perforin and elevated SHIP-1 expression is associated with functional anergy of natural killer cells in chronic HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

FcRL6, a new ITIM-bearing receptor on cytolytic cells, is broadly expressed by lymphocytes following HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Evolution of innate and adaptive effector cell functions during acute HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Allelic polymorphisms in the FcgammaRIIC gene can influence its function on normal human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Human natural killer cell deficiencies and susceptibility to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

A novel mutation in the FcgammaRIIIA gene (CD16) results in active natural killer cells lacking CD16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

FcgammaRIIa genotype predicts progression of HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

HIV's evasion of host's NK cell response and novel ways of its countering and boosting anti-HIV immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Activation, coactivation, and costimulation of resting human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Serum and cerebrospinal fluid levels of soluble intercellular adhesion molecule 1 (sICAM-1) in patients with HIV-1 associated neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Facing the enigma of immunomodulatory effects of intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Humoral immunity to HIV-1: neutralization and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Fc receptor but not complement binding is important in antibody protection against HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Viral strategies for evading antiviral cellular immune responses of the host

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Viral subversion of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

HIV Tat represses transcription of the beta 2-microglobulin promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

HIV's evasion of the cellular immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Inability of natural killer cells to destroy autologous HIV-infected T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Human immunodeficiency virus 1 downregulates cell surface expression of the non-classical major histocompatibility class I molecule HLA-G1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

HAART induces the expression of HLA-G on peripheral monocytes in HIV-1 infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Activation and self-tolerance of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Perturbation of natural killer cell function and receptors during HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Expression and function of NK cell receptors in CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Low levels of perforin expression in CD8+ T lymphocyte granules in lymphoid tissue during acute human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Association of circulating receptor Fc gamma RIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

CD27 and CD57 expression reveals atypical differentiation of human immunodeficiency virus type 1-specific memory CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Accelerated immune senescence and HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T lymphocytes during active, latent, and resolved infection and its relation with CD57

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Regulation of T cell function by NK cell receptors for classical MHC class I molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Differential regulation of killer cell lectin-like receptor G1 expression on T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Augmentation of NK cell-mediated cytotoxicity to tumor cells by inhibitory NK cell receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Molecular signature of CD8+ T cell exhaustion during chronic viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

HIV and SIV CTL escape: implications for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

CD8+ T-cells: function and response to HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

CTL ontogeny and viral escape: implications for HIV-1 vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

HLA-class I-specific inhibitory receptors in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

NK cell activation by dendritic cells is dependent on LFA-1-mediated induction of calcium-calmodulin kinase II: inhibition by HIV-1 Tat C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Reciprocal activating interaction between natural killer cells and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Dendritic and natural killer cells cooperate in the control/switch of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Essential role of the TNF-TNFR2 cognate interaction in mouse dendritic cell-natural killer cell crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Effector and regulatory events during natural killer-dendritic cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

CD161B:ClrB interactions mediate activation of enhanced lysis of tumor target cells following NK cell:DC co-culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

HIV-1 Nef impairs the dynamic of DC/NK crosstalk: different outcome of CD56(dim) and CD56(bright) NK cell subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

T cell apoptosis by tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Natural killer cells and malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Innate immune response of the human host to exposure with herpes simplex virus type 1: in vitro control of the virus infection by enhanced natural killer activity via interleukin-15 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

HIV type 1 Tat protein inhibits interleukin 12 production by human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

HIV-1 Tat triggers TGF-beta production and NK cell apoptosis that is prevented by pertussis toxin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Studies on the production of IL-15 in HIV-infected/AIDS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Impaired interleukin 12 production in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Type I interferon production in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

TGF beta and HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Elevated levels of circulating interleukin-18 in human immunodeficiency virus-infected individuals: role of peripheral blood mononuclear cells and implications for AIDS pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Interleukin-7 receptor expression on CD8(+) T cells is reduced in HIV infection and partially restored with effective antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Natural killer cells in antiviral defense: function and regulation by innate cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Natural killer type 2 bias in remission of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Involvement of human natural killer cells in asthma pathogenesis: natural killer 2 cells in type 2 cytokine predominance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Human IL-18 receptor and ST2L are stable and selective markers for the respective type 1 and type 2 circulating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Regulation of ST2L expression on T helper (Th) type 2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Infection of natural killer cells by human herpesvirus 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Isolation of primary HIV-1 that target CD8+ T lymphocytes using CD8 as a receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Proliferative activation up-regulates expression of CD4 and HIV-1 co-receptors on NK cells and induces their infection with HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

IL-15 and HIV infection: lessons for immunotherapy and vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Receptor-induced death in human natural killer cells: involvement of CD16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

HIV Tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Role of FAS in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Primary Cytotoxicity against the Envelope Glycoprotein of Human Immunodeficiency Virus-It Evidence for Antibody-Dependent Cellular Cytotoxicity In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Molecular events associated with CD4-mediated Down-regulation of LFA-1-dependent adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Inhibition of natural killer cell cytotoxicity and interferon gamma production by the envelope protein of HIV and prevention by vasoactive intestinal peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Presence of HLA-C-restricted cytotoxic T-lymphocyte responses in long-term nonprogressors infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Cellular immune responses to HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

In silico characterization of immunogenic epitopes presented by HLA-Cw*0401

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

The influence of autologous lymphokine-activated killer cell infusions on the toxicity and antitumor effect of repetitive cycles of interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Human NKG2F is expressed and can associate with DAP12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Targeted lysis of HIV-infected cells by natural killer cells armed and triggered by a recombinant immunoglobulin fusion protein: implications for immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Human embryonic stem cell-derived NK cells acquire functional receptors and cytolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

2B4 expression on natural killer cells increases in HIV-1 infected patients followed prospectively during highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

The CD16+ Monocyte Subset Is More Permissive to Infection and Preferentially Harbors HIV-1 In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

HIV/AIDS: Allied responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907649

21 January 2018

Identifiers

DOI

10.1189/JLB.0907649

1 reference

18 August 2017

1 reference